The transition into sophomore year of college is typically defined by a sense of growing independence and academic momentum. For Grace Taylor, that transition was severed by a single conversation in a doctor’s office. At 19 years old, Taylor was told she had a rare and aggressive form of thyroid cancer that had been growing unchecked for years.
The diagnosis was stark. The cancer had already migrated across her lymph nodes, wrapped around her vocal cords, pressed against the base of her skull, and encircled her windpipe. In that moment, Taylor recalls feeling as though the life she had envisioned was effectively over.
Now 22, the Dedham resident is preparing for a different kind of endurance test. Taylor is training to run the Boston Marathon to raise funds and awareness for Massachusetts General Hospital (MGH), the institution that provided the specialized care necessary for her survival. For Taylor, the 26.2-mile trek from Hopkinton to Boston is not merely an athletic achievement, but a public act of gratitude for the medical team and support systems that allowed her to reclaim her future.
A specialized approach to aggressive cancer
The complexity of Taylor’s case required a multidisciplinary approach. She was treated by a team at Massachusetts General Hospital, including Dr. Stephen, Dr. Barbesino, and Dr. Abrams, who developed a specialized treatment plan to address the spread of the malignancy.
Central to her recovery was the employ of radioactive iodine therapy, a treatment MGH helped pioneer. This targeted approach allows clinicians to destroy thyroid cancer cells while minimizing damage to surrounding healthy tissue, a critical factor given how closely the tumor had wrapped around Taylor’s vocal cords and pressed against her skull.
The success of the intervention allowed Taylor to maintain a trajectory that many cancer patients struggle to preserve. She not only survived the aggressive disease but graduated from Harvard University on schedule and continued her participation on the university’s lacrosse team, returning to the competitive athletics that now fuel her marathon training.
Addressing the isolation of young adult oncology
While the clinical treatment addressed the physical tumor, Taylor describes the psychological burden of navigating a life-threatening illness as a college student as “overwhelming, and isolating.” The experience of Adolescent and Young Adult (AYA) cancer patients differs significantly from pediatric or geriatric patients, as they often face the disruption of critical developmental milestones, such as higher education and early career entry.
To combat this, Taylor joined a survivorship class led by Dr. Zeba Ahmad. The AYA program focuses on the unique psychosocial needs of young adults, providing a space where patients can connect with peers who share similar lived experiences. Taylor notes that this program was the first time she felt truly seen by others her own age who understood the specific pressures of battling cancer while in college.
These survivorship resources, including the classes and educational materials, are offered at no cost to patients, funded entirely through philanthropic contributions. This necessity for external funding is a primary driver for Taylor’s decision to run the marathon.
Timeline of Recovery and Resilience
| Stage | Key Milestone | Outcome/Impact |
|---|---|---|
| Diagnosis | Age 19 (Sophomore Year) | Identified rare, aggressive thyroid cancer spread to lymph nodes and skull base. |
| Treatment | MGH Specialized Care | Underwent pioneered radioactive iodine therapy and targeted surgical plans. |
| Recovery | Academic & Athletic Return | Graduated from Harvard on time; continued playing lacrosse. |
| Advocacy | AYA Survivorship Program | Joined peer support classes to address the isolation of young adult cancer. |
| Giving Back | 2026 Boston Marathon | Running 26.2 miles to fund MGH and AYA programs. |
The significance of the 26.2-mile trek
For many, the Boston Marathon is a test of physical limits. For Taylor, the race is a symbolic representation of her survival. The ability to run—a physical act that requires the very respiratory and systemic health that the cancer threatened—is a victory in itself.
“Every mile I run will be in gratitude to my doctors, to the AYA program, to my survivorship friends, and to every patient who sits in a hospital room feeling scared and alone,” Taylor said. “I know how much this mission matters because I was one of those patients.”
By fundraising for the AYA program, Taylor aims to ensure that future young adults facing similar diagnoses do not have to navigate the isolation of cancer alone. The goal is to sustain the free resources and peer-led support systems that she credits with changing her life after the clinical battle was won.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a healthcare professional for diagnosis and treatment of any medical condition.
Taylor continues her training regimen in preparation for the race. The next major milestone for her campaign will be the final fundraising push leading up to race day, as she seeks to maximize the impact for the AYA program at Mass General.
We invite you to share your thoughts or stories of resilience in the comments below.
